Vanda Pharmaceuticals Ratios (2009-2025) | VNDA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Profitability
Gross Margin (Quarter)	90.38%	90.33%	90.30%	90.83%	90.59%	90.59%	90.32%	90.33%	92.36%	92.40%	92.11%	92.36%	92.75%	94.59%	94.65%	95.13%	92.96%	94.80%	94.75%	93.30%
EBT Margin (Quarter)	16.64%	18.56%	15.30%	12.66%	-12.57%	5.89%	8.36%	14.91%	8.85%	5.63%	-0.31%	-3.67%	-9.83%	-10.93%	-13.10%	-12.22%	-74.67%	-66.34%	-50.46%	-66.42%
EBIT Margin (Quarter)	16.50%	18.22%	15.43%	12.70%	-12.74%	5.38%	5.98%	10.28%	3.21%	-6.23%	-15.45%	-15.67%	-19.46%	-20.10%	-23.08%	-19.33%	-81.99%	-73.21%	-55.61%	-70.53%
EBITDA Margin (Quarter)	17.05%	18.72%	15.92%	13.19%	-12.20%	5.86%	6.44%	10.72%	3.67%	-5.74%	-14.93%	-15.22%	-19.02%	-19.67%	-22.63%	-18.91%	-81.53%	-72.71%	-55.07%	-70.00%
Operating Margin (Quarter)	16.50%	18.22%	15.43%	12.70%	-12.74%	5.38%	5.98%	10.28%	3.21%	-6.23%	-15.45%	-15.67%	-19.46%	-20.10%	-23.08%	-19.33%	-81.99%	-73.21%	-55.61%	-70.53%
Net Margin (Quarter)	13.77%	14.14%	11.09%	10.44%	-10.74%	4.00%	4.99%	10.64%	5.20%	3.24%	0.35%	-5.30%	-8.74%	-8.95%	-11.21%	-9.17%	-58.89%	-51.73%	-40.15%	-246.83%
FCF Margin (Quarter)	14.46%	27.57%	13.42%	38.92%	6.60%	8.53%	19.43%	14.19%	50.80%	-28.82%	-5.34%	-8.80%	15.93%	-13.94%	-30.94%	-3.82%	-67.11%	-29.57%	-56.50%	-51.59%
Efficiency
Inventory Average (Quarter)	3.80M	3.68M	0.98M	0.96M	1.16M	5.44M	5.59M	6.54M	6.30M	5.64M	5.59M	5.61M	10.06M	5.69M	1.54M	1.67M	1.82M	2.05M	6.10M	10.53M
Assets Average (Quarter)	538.32M	555.42M	573.71M	586.78M	598.67M	606.33M	615.45M	628.02M	639.39M	643.11M	641.64M	645.02M	650.56M	652.03M	648.24M	650.66M	644.07M	628.34M	612.94M	545.04M
Equity Average (Quarter)	460.45M	474.42M	487.27M	499.12M	503.53M	505.34M	512.10M	521.43M	531.47M	537.82M	541.50M	544.00M	544.45M	543.26M	541.87M	539.88M	524.98M	498.87M	476.16M	396.59M
Invested Capital (Quarter)	467.63M	481.22M	493.32M	504.93M	502.12M	508.55M	515.66M	527.20M	535.74M	539.90M	543.10M	544.91M	544.00M	542.52M	541.22M	543.51M	511.42M	486.33M	466.00M	334.67M
Asset Utilization Ratio (Quarter)	0.47	0.47	0.47	0.46	0.44	0.43	0.42	0.41	0.40	0.37	0.33	0.30	0.27	0.28	0.29	0.31	0.31	0.32	0.35	0.40
Leverage & Solvency
Equity Ratio (Quarter)	0.86	0.85	0.85	0.85	0.83	0.83	0.83	0.83	0.83	0.84	0.85	0.84	0.83	0.83	0.84	0.82	0.81	0.78	0.78	0.67
Valuation
Enterprise Value (Quarter)	-378.16M	-396.49M	-405.97M	-432.81M	-435.18M	-440.86M	-454.79M	-466.86M	-501.50M	-489.35M	-489.86M	-388.26M	-394.14M	-387.68M	-376.26M	-374.64M	-340.91M	-325.55M	-293.75M	-263.85M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	0.00%	-0.02%
Return on Capital Employed (Quarter)	7.91%	8.46%	8.77%	8.23%	4.76%	2.94%	1.59%	1.18%	2.93%	1.74%	-0.04%	-2.50%	-4.52%	-5.82%	-6.70%	-7.38%	-13.41%	-19.89%	-24.46%	-37.80%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%

Research Tools

Vanda Pharmaceuticals Ratios (2009-2025) | VNDA

Create an account

Sign In

Reset Password